AWARD NOMINATION

Lifestyle

Boehringer Ingelheim Will Test an Obesity Medication in Three Late-Stage Trials

By Gazet InternationalOctober 1, 2023Updated:October 10, 20231 Min Read

#BOEHRINGER #GAZET #GIAWARDS #HEALTH #PHARMACEUTICALS #SCIENCE #WEIGHTLOSS

Previous ArticleSurvey Shows Almost Half of Australia’s Elite Athletes Live in Poverty

Next Article Research Shows Fewer Than 5000 Steps A Day is Sufficient to Improve Health